Author: Mintel Group Ltd.
Last saved by: HTTP server

Bodycare and Deodorant: Inc Impact of COVID-19 - US - June 2020
Overview
 
What you need to know 
While COVID-19 is expected to cause slowed sales growth, the bodycare and deodorant markets are expected to maintain positive sales through 2025, thanks to the hygiene staple status of most products. Incorporating unique formats or ingredients that are typically found in facial skincare products can help persuade consumers to look beyond the functional nature of bodycare and APDO categories, creating opportunities to sustain longer-term growth. 

Key issues covered in this Report
●	The impact of COVID-19 on consumer behavior and the bodycare and deodorant market
●	How the market will fare in a post-COVID-19 down economy 
●	Consumers’ bodycare and APDO behaviors and usage of products
●	Launch activity and consumer interest in product innovations

This Report was written May – June, 2020 and updated on June 24, 2020 with the COVID-19 implications. 

Definition 
This Report includes deodorants and antiperspirants in all packaging formats, including aerosols, sprays, pumps, roll-ons, solid sticks and gels, as well as body care products such as lotions, oils and creams. Hand lotion is included in the market size, but grouped with body lotion in market segmentation, as there are few products that are marketed specifically for hand care.

For the purposes of this Report, the body care and deodorant market has been segmented as follows:

Definition should always include:

●	Hand and body care, which includes hand and body lotions, body oils, anti-aging body creams and hand creams
●	APDO (Antiperspirants/deodorants) 

Excluded are: foot care, body cleansing products (ie body wash), products designed for use on facial skin, foot care devices or medicated foot care products, such as athlete’s foot medication.

This report is supplied in accordance with Mintel's terms and conditions.  
© Mintel Group Ltd.